Literature DB >> 16434376

Iron overload due to mutations in ferroportin.

Ivana De Domenico1, Diane McVey Ward, Giovanni Musci, Jerry Kaplan.   

Abstract

Iron overload disease due to mutations in ferroportin has a dominant inheritance and a variable clinical phenotype, such that some patients show early Küpffer cell iron loading and low transferrin saturation, while others show hepatocyte iron loading and high transferrin saturation. Studies expressing ferroportin mutant proteins in cultured cells have shown that mutant proteins fall into two main classes; proteins that do not localize to the cell surface and are unable to export iron, and those that localize to the cell surface but are unable to respond to the antimicrobial peptide hepcidin. Patients with mutant ferroportin proteins that do not localize to the cell surface show typical ferroportin disease with low transferrin saturation and early Küpffer cell iron loading, while patients with mutant proteins unable to respond to hepcidin show high transferrin saturation and early hepatocyte iron loading similar to classic hereditary hemochromatosis. The dominant genetic transmission of ferroportin-linked disorders is explained by the in vitro data, which suggest that ferroportin is a multimer and that the behavior of the mutant protein can affect the behavior of the wild type protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434376      PMCID: PMC3718253     

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  20 in total

1.  Genetic disorders of iron overload and the novel "ferroportin disease".

Authors:  Mario Cazzola
Journal:  Haematologica       Date:  2003-07       Impact factor: 9.941

2.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

3.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

4.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.

Authors:  A Donovan; A Brownlie; Y Zhou; J Shepard; S J Pratt; J Moynihan; B H Paw; A Drejer; B Barut; A Zapata; T C Law; C Brugnara; S E Lux; G S Pinkus; J L Pinkus; P D Kingsley; J Palis; M D Fleming; N C Andrews; L I Zon
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

5.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

6.  Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice.

Authors:  Henry Mok; Jaroslav Jelinek; Sonia Pai; Bruce M Cattanach; Josef T Prchal; Hagop Youssoufian; Armin Schumacher
Journal:  Development       Date:  2004-04       Impact factor: 6.868

Review 7.  The ferroportin disease.

Authors:  Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

8.  Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene.

Authors:  A Pietrangelo; G Montosi; A Totaro; C Garuti; D Conte; S Cassanelli; M Fraquelli; C Sardini; F Vasta; P Gasparini
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

9.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.

Authors:  G Montosi; A Donovan; A Totaro; C Garuti; E Pignatti; S Cassanelli; C C Trenor; P Gasparini; N C Andrews; A Pietrangelo
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 10.  Hereditary hemochromatosis--a new look at an old disease.

Authors:  Antonello Pietrangelo
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  15 in total

Review 1.  Flatiron mice and ferroportin disease.

Authors:  Erin E Johnson; Marianne Wessling-Resnick
Journal:  Nutr Rev       Date:  2007-07       Impact factor: 7.110

Review 2.  Mammalian iron metabolism and its control by iron regulatory proteins.

Authors:  Cole P Anderson; Macy Shen; Richard S Eisenstein; Elizabeth A Leibold
Journal:  Biochim Biophys Acta       Date:  2012-05-17

3.  Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts.

Authors:  De-Liang Zhang; Thomas Senecal; Manik C Ghosh; Hayden Ollivierre-Wilson; Tiffany Tu; Tracey A Rouault
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

4.  Chronic inflammation and iron metabolism.

Authors:  Erin A Osterholm; Michael K Georgieff
Journal:  J Pediatr       Date:  2015-02-13       Impact factor: 4.406

Review 5.  Hereditary hemochromatosis and transferrin receptor 2.

Authors:  Juxing Chen; Caroline A Enns
Journal:  Biochim Biophys Acta       Date:  2011-08-16

Review 6.  Recent advances in iron metabolism and related disorders.

Authors:  Clara Camaschella; Paolo Strati
Journal:  Intern Emerg Med       Date:  2010-04-28       Impact factor: 3.397

7.  Role of ferroportin in macrophage-mediated immunity.

Authors:  Erin E Johnson; Andreas Sandgren; Bobby J Cherayil; Megan Murray; Marianne Wessling-Resnick
Journal:  Infect Immun       Date:  2010-09-13       Impact factor: 3.441

8.  Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.

Authors:  Ivana De Domenico; Eric Lo; Diane M Ward; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

9.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

10.  The hepcidin-binding site on ferroportin is evolutionarily conserved.

Authors:  Ivana De Domenico; Elizabeta Nemeth; Jenifer M Nelson; John D Phillips; Richard S Ajioka; Michael S Kay; James P Kushner; Tomas Ganz; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.